Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318306-07-000003
Filing Date
2007-01-08
Accepted
2007-01-08 14:44:35
Documents
1
Period of Report
2007-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2054
  Complete submission text file 0000318306-07-000003.txt   4077
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O BIOENVISION INC 509 MADISON AVE SUITE 404 NEW YORK NY 10022 2127506700
LUCI DAVID P (Reporting) CIK: 0001271123 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 07517221